Tirzepatide Improves Sleep Apnea in Patients With Obesity, Drugmaker Says

Topline results add yet another potential reason for use of dual GIP/GLP-1 receptor agonist

Related Keywords

California ,United States ,New York ,Florida ,Orlando ,American ,Holly Lofton ,Eli Lilly ,Ttirzepatide Zepbound ,Dan Azagury ,Stanford Health In Palo Alto ,American Diabetes Association ,New York City ,Stanford Health ,Palo Alto ,Medpage Today ,